Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

Nvidia’s Story Still Intact, But Be Cautious

By Todd Shriber, InvestorPlace Contributor

Nvidia is rumored to be considering a major acquisition, but the numbers indicate NVDA stock can deliver growth without a big deal.

3 Gun Stocks to Consider for Portfolio Protection

By Todd Shriber, InvestorPlace Contributor

Gun stocks aren't for everyone, but for investors that like the idea of small-cap portfolio power, there are few names to consider here.

The Worst May Not Be Over for General Electric

By Todd Shriber, InvestorPlace Contributor

GE stock entered 2020 with two problems: power and capital. Now it has a third in its aviation business due to Covid-19.

XpresSpa Is in a Tough Place With Covid-19 Still in Play

By Todd Shriber, InvestorPlace Contributor

With air travel and consumer spending still nowhere near pre-coronavirus levels, XSPA stock is a risky idea, to put it mildly.

5 Dental Stocks to Buy For Big Smiles As Coronavirus Fears Ease

By Todd Shriber, InvestorPlace Contributor

Dental stocks offer some risk, but some members of this industry have exciting growth prospects, particularly when Covid-19 is erased.

3 Psychedelic Stocks for Healthcare Investors

By Todd Shriber, InvestorPlace Contributor

Psychedelic stocks are still small and not getting much attention, but those could actually positive traits for prescient investors.

7 Great ETFs to Buy for the Rise of 5G

By Todd Shriber, InvestorPlace Contributor

5G is here and its deployment could be epic. Investors can get on the action with some of the following 5G ETFs.

Sintx Joins List of Highly Speculative Covid-19 Plays

By Todd Shriber, InvestorPlace Contributor

Sintx Technologies stock could be meaningful to investors as it's one of several smaller companies that offers a way to play the pandemic.

American Airlines Stock Will Remain Turbulent for Awhile

By Todd Shriber, InvestorPlace Contributor

American Airlines is doing everything it can to survive, but its capacity outlook is a warning sign for those considering buying AAL stock.

The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks

By Todd Shriber, InvestorPlace Contributor

Inovio Pharmaceuticals (NASDAQ:INO) is a contender in the hyper-competitive field to develop a novel coronavirus vaccine, but with the company falling behind rivals, INO stock…

Load More